Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05735379Phase 4Recruiting
Phase 4, open-label, single-arm trial, sponsored by Centre de recherche du CHUS. Primary endpoint: Change in gait capacity measured in the lab at 4 months. Started Mar 2023; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05735379.